OverviewChartNewsTraderScreen

PTC Therapeutics/  US69366J2006  /

IEX
2024-05-03  9:59:58 PM Chg. -0.60 Volume Bid- Ask- High Low
32.99USD -1.79% 42,081
Turnover: 1.4 mill.		 -Bid Size: - -Ask Size: - 34.65 32.83
GlobeNewswire 03-19 ClearPoint Neuro Congratulates its Partner PTC Therapeutics on Completion of Biologics License Appli...
GlobeNewswire 02-15 Royalty Pharma Reports Q4 and Full Year 2023 Results
GlobeNewswire 01-26 PTCT ALERT: Johnson Fistel Encourages Investors to Inquire About PTC Therapeutics Securities Class A...
GlobeNewswire 01-03 US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Haltin...
GlobeNewswire 2023-12-07 Cassava Sciences Appoints Three New Members to its Board of Directors
GlobeNewswire 2023-11-08 Royalty Pharma Reports Third Quarter 2023 Results
GlobeNewswire 2023-11-07 Replimune Reports Fiscal Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 2023-10-19 Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Ev...
GlobeNewswire 2023-09-19 Replimune Announces Appointment of Emily Hill as Chief Financial Officer
GlobeNewswire 2023-09-12 Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of ...
GlobeNewswire 2023-08-28 Muscular Dystrophy Association Kicks Off 30 Days of Strength Campaign for National Muscular Dystroph...
GlobeNewswire 2021-12-02 Praxis Precision Medicines Announces Management Team Appointments
GlobeNewswire 2021-11-08 Ring Therapeutics Strengthens Leadership Team with Three Executive Appointments
GlobeNewswire 2021-09-13 Aadi Bioscience Appoints Emma Reeve to its Board of Directors
GlobeNewswire 2021-08-23 Adverum Appoints Global Regulatory Leader Jim Wang, Ph.D., as Senior Vice President, Head of Regulat...
GlobeNewswire 2021-05-06 Albireo Reports Q1 Financial Results and Business Update
GlobeNewswire 2021-04-15 Adverum Files Definitive Proxy Materials and Mails Letter to Stockholders Detailing Strength of Team...
GlobeNewswire 2021-04-14 CohBar to Present at the Mitochondria-Targeted Drug Development Summit
GlobeNewswire 2021-03-17 Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value...
GlobeNewswire 2021-03-02 Orchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments
GlobeNewswire 2021-02-22 Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer
GlobeNewswire 2021-01-29 Orchard Therapeutics Appoints Braden Parker as Chief Commercial Officer
GlobeNewswire 2021-01-14 Congenica Launches Patient Advocacy and Engagement Advisory Board
GlobeNewswire 2021-01-07 LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies for Rare a...
GlobeNewswire 2020-12-29 ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improve...